Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D S Rampton

Showing results (21-30 of 125) with videos related to

Pageof 13
Sort By:
Gastroenterology|November 1, 1985
Prostaglandins and the gastrointestinal mucosa: are they important in its function, disease, or treatment?C J Hawkey, D S Rampton
Gut|January 1, 1995
Platelet dysfunction: a new dimension in inflammatory bowel diseaseC E Collins, D S Rampton
Postgraduate Medical Journal|May 1, 1981
Relapse of ulcerative proctocolitis during treatment with non-steroidal anti-inflammatory drugsD S Rampton, G E Sladen
Alimentary Pharmacology & Therapeutics|August 16, 2014
Commentary: predictors of severe outcomes associated with Clostridium difficile infection in inflammatory bowel disease patientsN M Joshi, D S Rampton
Diseases of the Colon and Rectum|November 1, 1981
Is the rectum usually empty?--A quantitative study in subjects with and without diarrheaN I McNeil, D S Rampton
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 14, 2005
Leucocytapheresis for ulcerative colitisP M Irving, D S Rampton
Gut|July 1, 1993
Inflammatory bowel disease--a radical viewN J Simmonds, D S Rampton
Prostaglandins|March 1, 1981
Prostaglandin synthesis inhibitors in ulcerative colitis: flurbiprofen compared with conventional treatmentD S Rampton, G E Sladen
Alimentary Pharmacology & Therapeutics|December 1, 1991
The pro-drug sulindac may reduce the risk of intestinal damage associated with the use of conventional non-steroidal anti-inflammatory drugsG R Davies, D S Rampton
Gastroenterology|December 1, 1990
Eicosanoids in amebiasisD S Rampton, D J Gertner
Pageof 13

Showing results (21-30 of 125) with videos related to

Sort By:
Pageof 13
Gastroenterology|November 1, 1985
Prostaglandins and the gastrointestinal mucosa: are they important in its function, disease, or treatment?C J Hawkey, D S Rampton
Gut|January 1, 1995
Platelet dysfunction: a new dimension in inflammatory bowel diseaseC E Collins, D S Rampton
Postgraduate Medical Journal|May 1, 1981
Relapse of ulcerative proctocolitis during treatment with non-steroidal anti-inflammatory drugsD S Rampton, G E Sladen
Alimentary Pharmacology & Therapeutics|August 16, 2014
Commentary: predictors of severe outcomes associated with Clostridium difficile infection in inflammatory bowel disease patientsN M Joshi, D S Rampton
Diseases of the Colon and Rectum|November 1, 1981
Is the rectum usually empty?--A quantitative study in subjects with and without diarrheaN I McNeil, D S Rampton
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 14, 2005
Leucocytapheresis for ulcerative colitisP M Irving, D S Rampton
Gut|July 1, 1993
Inflammatory bowel disease--a radical viewN J Simmonds, D S Rampton
Prostaglandins|March 1, 1981
Prostaglandin synthesis inhibitors in ulcerative colitis: flurbiprofen compared with conventional treatmentD S Rampton, G E Sladen
Alimentary Pharmacology & Therapeutics|December 1, 1991
The pro-drug sulindac may reduce the risk of intestinal damage associated with the use of conventional non-steroidal anti-inflammatory drugsG R Davies, D S Rampton
Gastroenterology|December 1, 1990
Eicosanoids in amebiasisD S Rampton, D J Gertner
Pageof 13